This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Andrade, R.J. Articles by Gonzalez-Santos, P. Search for Related Content PubMed PubMed Citation Articles by Andrade, R.J. Articles by Gonzalez-Santos, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOSPORIN A Social Bookmarking                         What's this?

Short-Term Effect of Various Doses of Cyclosporin A on Plasma Lipoproteins and its Distribution in Blood: An Experimental Study

Department of Medicine, University Hospital, School of Medicine, Malaga, Spain

M.I. Lucena

Department of Clinical Pharmacology, University Hospital, School of Medicine, Malaga, Spain

J.A. Gonzalez-Correa

Department of Clinical Pharmacology, University Hospital, School of Medicine, Malaga, Spain

C. Garcia-Arias

Department of Medicine, University Hospital, School of Medicine, Malaga, Spain

P. Gonzalez-Santos

Department of Medicine, University Hospital, School of Medicine, Malaga, Spain

Hyperlipidaemia commonly develops in both transplant recipients and experimental animals receiving cyclosporin A (CsA). However, the threshold of CsA induced-changes on lipoproteins and the role of parenteral vehicle (cremophor) has not been defined.

Male Wistar rats were classified into five groups of six animals each and received CsA in cremophor vehicle at doses of 5, 10 or 20 mg kg^-1 d^-1, s.c., vehicle alone or saline for 7 d. Blood was obtained 24 h after the last dose and plasma was analysed. Plasma very low density lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein subfractions (HDL-2, HDL-3) were isolated by sequential ultracentrifugation and their content of cholesterol, triglyceride and phospholipid was determined. Whole blood and trough plasma CsA levels were measured by monoclonal radioimmunoassay.

Plasma lipids did not differ significantly among the five groups. At a dose of 20 mg kg^-1 d^-1 of CsA VLDL cholesterol rose significantly (P<0.05). Administration of either CsA or cremophor vehicle increased HDL-2 phospholipids (P<0.05) and decreased HDL-3 cholesterol. There was not a linear relationship between whole blood and plasma CsA levels and increasing CsA doses.

Short-term treatment with low doses of CsA have little influence on lipid profile in the rat. Changes on lipoprotein composition can be attributed mainly to cremophor vehicle, conceivably due to its ethanol content.

Human & Experimental Toxicology, Vol. 12, No. 2, 141-146 (1993)
DOI: 10.1177/096032719301200208


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?